Validation of Biomarkers of CVD Risk from Dried Blood Spots in Community-Based Research: Methodologies and Study-Specific Serum Equivalencies
| Autor: | Thomas W. McDade, Orfeu M. Buxton, Laura B. Samuelsson, Grace Sembajwe, Martica H. Hall, Shakir McLean, James H. Porter, Miguel Marino, Lisa F. Berkman |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Quality Control Analyte Pathology medicine.medical_specialty Article Young Adult Internal medicine Linear regression Genetics Humans Medicine Clinical significance Generalizability theory Ecology Evolution Behavior and Systematics Aged Demography Dried Blood Spot Testing Venipuncture biology business.industry Cholesterol HDL C-reactive protein Reproducibility of Results Middle Aged Dried blood spot C-Reactive Protein Cholesterol surgical procedures operative Cardiovascular Diseases Anthropology biology.protein Regression Analysis Female business Biomarkers |
| Zdroj: | Biodemography and Social Biology. 61:285-297 |
| ISSN: | 1948-5573 1948-5565 |
| Popis: | Dried blood spot (DBS) methodology offers significant advantages over venipuncture in studies of vulnerable populations or large-scale studies, including reduced participant burden and higher response rates. Uncertainty about the validity of cardiovascular disease (CVD) risk biomarkers remains a barrier to wide-scale use. We determined the validity of DBS-derived biomarkers of CVD risk versus gold-standard assessments, and study-specific, serum-equivalency values for clinical relevance of DBS-derived values. Concurrent venipuncture serum and DBS samples (n = 150 adults) were assayed in Clinical Laboratory Improvement Amendments-certified and DBS laboratories, respectively. Time controls of DBS standard samples were assayed single-blind along with test samples. Linear regression analyses evaluated DBS-to-serum equivalency values; agreement and bias were assessed via Bland-Altman plots. Linear regressions of venipuncture values on DBS-to-serum equivalencies provided R(2) values for total cholesterol, high-density lipoprotein cholesterol (HDL-C), and C-reactive protein (CRP) of 0.484, 0.118, and 0.666, respectively. Bland-Altman plots revealed minimal systematic bias between DBS-to-serum and venipuncture values; precision worsened at higher mean values of CRP. Time controls revealed little degradation or change in analyte values for HDL-C and CRP over 30 weeks. We concluded that DBS-assessed biomarkers represent a valid alternative to venipuncture assessments. Large studies using DBS should include study-specific serum-equivalency determinations to optimize individual-level sensitivity, the viability of detecting intervention effects, and generalizability in community-level primary prevention interventions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|